Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | RARB | P10826 | 4/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | LPL | P06858 | 4/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2555796 | 0.96 | RARB (0.58) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL5392482 | 0.95 | RARB (0.60) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL3039053 | 0.95 | RARB (0.60) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL7698504 | 0.95 | RARB (0.60) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL1792038 | 0.95 | RARB (0.60) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL623764 | 0.94 | CA1 (0.57) | CA1CA2LPLLIPGLTA4H | |
| SCHEMBL9893658 | 0.93 | LTA4H (0.50) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL1006706 | 0.91 | NR5A1 (0.61) | RARBCA1CA2LPLLIPG | |
| SCHEMBL2401172 | 0.89 | NR5A1 (0.65) | RARBCA1CA2LPLLIPG | |
| SCHEMBL7472946 | 0.89 | NR5A1 (0.65) | RARBCA1CA2LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107075377-B | Device for regulating the passage of energy | 默克专利股份有限公司 | 2020-08-11 | — | — | CN | disclosed |
| EP-3186334-B1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY | MERCK PATENT GMBH (DE) | 2019-09-25 | — | — | EP | disclosed |
| US-10370592-B2 | Device for regulating the passage of energy | MERCH PATENT GMBH (DE) | 2019-08-06 | — | — | US | disclosed |
| US-20170267929-A1 | DEVICE FOR REGULATING THE PASSAGE OF ENERGY | MERCK PATENT GMBH (DE) | 2017-09-21 | — | — | US | disclosed |
| EP-3186334-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY | Merck Patent GmbH (DE) | 2017-07-05 | — | — | EP | disclosed |
| WO-2016029996-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY | MERCK PATENT GMBH (DE) | 2016-03-03 | — | — | WO | disclosed |
| US-9249136-B2 | 3H-naphtho [2,1-B] pyrans as photochromic dichroic dyes and optical article containing them | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2016-02-02 | — | — | US | disclosed |
| EP-2066650-B1 | 3H-NAPHTHO[2,1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INT (FR) | 2011-12-21 | — | — | EP | disclosed |
| US-20100202033-A1 | 3H-NAPHTH0 [2,1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D' OPTIQUE) (FR) | 2010-08-12 | — | — | US | disclosed |
| EP-2066650-A1 | 3H-NAPHTH0 [2, 1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) (FR) | 2009-06-10 | — | — | EP | disclosed |
| WO-2008030226-A1 | 3H-NAPHTH0 [2, 1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2008-03-13 | — | — | WO | disclosed |
| EP-0788511-B1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-12-11 | — | — | EP | disclosed |
| US-6265536-B1 | MICROBIOCIDE AND FUNGICIDE WHICH IS INHIBITOR OF BETA-1,3-GLUCAN SYNTHASE; TREATMENT OF PNEUMOCYSTIS CARINII INFECTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| US-6107458-A | FUNGICIDE WHICH IS BETA-1,3-GLYCAN SYNTHASE INHIBITOR; FOR PROPHYLAXIS AND TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS LIKE PNEUMONIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-22 | — | — | US | disclosed |
| EP-0788511-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996011210-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100202033-A1 | 3H-NAPHTH0 [2,1-B] PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | NR0B1, NR0B2, NR4A1 | CYP2D6 559/4885CYP3A4 417/4885CYP19A1 321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.